neoplasia

(redirected from Anal Intraepithelial Neoplasia)
Also found in: Dictionary, Thesaurus, Medical, Acronyms.

neoplasia

[‚nē·ə′plā·zhə]
(medicine)
Formation of a neoplasm or tumor.
Formation of new tissue.
References in periodicals archive ?
A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod.
Several single-center studies in the combination antiretroviral therapy era have assessed the power of abnormal anal cytology to predict anal intraepithelial neoplasia (AIN) or other outcomes (Table 2).
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men.
We would expect the qHPV vaccine to protect against anal intraepithelial neoplasia [including anal condyloma] in the female and heterosexual male populations to a degree similar to that among men who have sex with men.
The purpose of this study was to review the literature about the use of anal cytology and anoscopy to screening and evaluation of anal intraepithelial neoplasia.
A 2009 meta-analysis of 93 studies from four continents reckoned HPV rates in people with vulvar, vaginal, or anal intraepithelial neoplasia grades 1 to 3 and carcinoma.
3% among 671 anal intraepithelial neoplasia (AIN)1 cases, 609 AIN 2/3 cases, and 955 anal carcinomas, respectively.
Anal intraepithelial neoplasia (AIN) is abnormal growth in anal tissue cekks that may develop into anal cancer in a small percentage of people.
HPV subtypes 16 and 18 are also associated with non-cervical malignancies, including vulval, penile, anal and oro-pharyngeal cancers, as well as precursor lesions such as anal intraepithelial neoplasia.
Individuals infected by the human immunodeficiency virus (HIV) have a high risk of infection by human papillomavirus (HPV), as well as a high incidence of anal intraepithelial neoplasia (AIN) and anal cancer caused by HPV [1].
In December 2010, the FDA approved a new indication for Gardasil, anal cancer and anal intraepithelial neoplasia grades 1, 2 and 3 in males and females between the age of 9 and 26, which is expected to drive the prophylactic cancer vaccine market.
Quadrivalent HPV vaccine efficacy against anal intraepithelial neoplasia in men having sex with men [Abstract].